Research News & Funding Opportunities for Tulane Cancer Researchers - May 21, 2024 | |
LSU / LCMC Health Cancer Center Seminar
Regulation of DNA Repair and Drug Resistance, From Bench to Bedside
Wenge Zhu, PhD
Professor
Department of Biochemistry & Molecular Medicine
The George Washington University School of Medicine & Health Science
Today - Noon - 1:00 PM
Louisiana Cancer Research Center Auditorium - 1st Floor
1700 Tulane Ave., New Orleans
Lunch Available at 11:45 AM
Zoom Meeting ID: 951 5880 5925
Passcode: 421004
| |
Louisiana Cancer Research Center
Tea Time
Today - 3:00 PM
Louisiana Cancer Research Center Lobby
1700 Tulane Ave., New Orleans
Join your cancer research colleagues at Tulane and the partner institutions of the LCRC for this casual networking opportunity. Light refreshments will be served.
| |
Educational Research Day
Wednesday, May 22 - 1 - 4 PM
Murphy Building, 131 S. Robertson
5th Floor, Leone Learning Center
The Office of Medical Education encourages all School of Medicine faculty, staff, residents, and students to attend Educational Research Day to learn about the work of others in the New Orleans Health Sciences community.
Posters will highlight Medical Education research in areas such as:
- Active or Team-Based Learning
- Faculty Development
- Curriculum Design & Assessment
- Simulation
- Technology Enhanced Learning
| |
School of Medicine Picture Day
Thursday, May 23 - 9:00 AM - 4:00 PM
Hutchinson, Room 1551
Free to all Tulane School of Medicine faculty, staff, residents, fellows and students.
Sign up for a time here and bring your white coat if you have one.
| |
|
LSU / LCMC Health Cancer Center Faculty Candidate Seminar
Innate Immunity, Epigenetic Restriction, and KSHV: A Recipe for Latency
Arunava Roy, PhD
Assistant Professor, Research
Department of Molecular Medicine
University of South Florida
Thursday, May 23 - Noon - 1:00 PM
Louisiana Cancer Research Center Auditorium - 1st Floor
1700 Tulane Ave., New Orleans
Lunch Available at 11:45 AM
Zoom Meeting ID: 971 0723 8240
Passcode: 846735
| |
Promising Practices Conference on Community Health
Friday, May 24
Grambling State University Online and Onsite
Presented by the Louisiana Cancer Research Center Office of Community Outreach and Engagement, this program is designed to support communities in improving health and wellness and reducing cancer in Louisiana. Community and health advocates from across the state are expected to attend.
REGISTER HERE
| |
NOMINATION DEADLINE EXTENDED
Tulane Research, Scholarship and Artistic Achievement Awards
The Office of Research announces the extension of the Research, Scholarship, and Artistic Achievement Awards nomination process to May 31, 2024. This will be the fourth year for these awards, which are given annually to honor outstanding scholars and recognize exceptional research achievement and impact on advancing knowledge, innovation, or creativity in science, engineering, health, arts, humanities, education, and other academic fields.
Please review the award categories and find this year’s nomination process instructions at https://research.tulane.edu/achievement-awards to nominate your faculty colleagues.
For assistance with the categories or instructions, please email Gail Louis at glouis@tulane.edu.
| |
|
Gilead's Research Scholars Program in HIV:
Building the Future Together
The Research Scholars Program supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuit of scientific understanding and progress. We believe that new, diverse voices and research topics are needed to advance scientific knowledge in areas of unmet medical need and create a healthier world.
The program is designed to support any innovative basic, clinical, behavioral, epidemiological, implementation science, and community-based participatory scientific research related to HIV. The Research Scholars Program is actively working towards reducing potential barriers to entry and success for applicants from population groups who are typically underrepresented in research. We are committed to supporting researchers and research projects addressing unmet patient needs and health inequities to build a more inclusive research landscape.
Gilead's Research Scholars Program now awards junior faculty researchers who are pursuing an academic career at an institution at the time of application with $180,000 USD in funding paid directly to the researchers' institution in 2 annual installments of $90,000 USD per year.
Scientific Focus:
The program is designed to support basic and clinical research in the field of HIV, in North America and globally. Areas of research may include, but are not limited to:
- Basic, clinical, behavioral, epidemiological, implementation science, and community-based participatory research
- Health inequities faced by certain population groups
- Management of complications, comorbidities, and/or co-infections e.g., HIV and aging
- HIV Prevention
- Digital Models and Artificial Intelligence (AI)
- Health economics outcomes research
Eligibility Criteria:
Applicants must meet the following requirements:
- Hold an MD, DO, PhD, or equivalent degree at the time of award
- Received your initial faculty appointment within the last 5 years at the time of application
- Have a strong career interest in HIV
- Have a research mentor with extensive experience in their field (co-mentorship is accepted)
- Be able to devote approximately 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
- Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects.
Click here to download the 2024 program brochure.
Click here for more information or to apply to the program.
Gilead will be holding a Q&A Webinar with the Scientific Review Committee on June 6, 11:00 AM - Noon CST. Please submit your questions no later than May 28.
Click here to register for the webinar.
| | |
NRSA Postdoctoral Research Fellowship
Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training
NIH-NRSA Training Grant - TL1 DK139566
Application Deadline: June 1, 5:00 PM
Applications Reviewed as Received
NIH-funded training grant post-doctoral fellowships are available for research training in the areas broadly related to Kidney, Urology, and non-malignant Hematology diseases. Trainees will pursue a one to two-year research program in the laboratory of an established basic or clinical research mentor, supplemented with training in advanced biostatistics and bioethics courses.
Trainees will be required to carry out an independent research project in the laboratory of a faculty mentor - a basic scientist or clinician investigator experienced in kidney, urology and non-malignant hematology disease-related research at Augusta University (AU), Tulane University (TU) or The University of Alabama at Birmingham (UAB). Current areas of research interest include renal transport physiology, acute and chronic kidney disease, diabetic kidney disease, cell and developmental biology pertaining to the kidney, polycystic kidney disease, hypertension, glomerular diseases, dialysis-related vascular access, lower urinary tract disease, inflammation and immunology, red cell pathology, nephrolithiasis, genetic diseases, sickle-cell disease, basic and clinical research in transplantation and outcomes/epidemiology research.
Selection of trainees is based on the demonstrated ability of the candidate and trainee’s career plan and potential for an academic career. Applicants must be United States citizens or permanent residents and have completed their MD or PhD by the start date of the fellowship.
More Information
| |
|
LA EPSCoR is now accepting applications for the following programs:
- LAMDA Seed Funding Track 1A: Single Investigator
- LAMDA Seed Funding Track 1B: Collaborative Partnership
- LAMDA Seed Funding Track 1C: Post-Doctoral Research
- LAMDA Seed Funding Track 2: Industrial Collaboration
- LAMDA Seed Funding Track 4: STEM Outreach
Deadline for proposals is Friday, June 7, 2024. Please follow this link to their online submission system -- https://laepscor.piestar-rfx.com/ -- and view the opportunities listed there. The RFPs will also be available on their website, https://rsi.laregents.edu/programs/epscor-programs/.
| |
NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
PAR-24-153
APPLICATION DUE DATE: JUNE 18, 2024
The purpose of the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12) is to support the training of clinical scientists in community cancer prevention, screening, intervention, control, and treatment research. Special emphasis is placed on training clinical scientists whose career goal is to improve the care and outcomes of minority health populations and populations with health disparities that are underrepresented in clinical research by increasing their access to and representation as human subjects in cancer clinical trials using an equity lens.
This Notice of Funding Opportunity (NOFO) allows the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; proposing to increase the integration of cancer health disparities research questions into clinical trials; or proposing a separate ancillary study to an existing prevention, screening, intervention, control or treatment trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of minority health populations and populations with health disparities that are underrepresented as human subjects in cancer clinical trials, as part of their research and career development.
| |
|
Forge AHEAD Pilot Grant Opportunity
The Forge AHEAD Program's new pilot grant opportunity -- made available through Tulane's partnership in the UAB Center for Clinical and Translational Science -- provides a 1-year, $50,000 award for applicants interested in conducting clinical, community, and population health research into cardiometabolic diseases. Interested applicants should also include health equity and social determinants of health components in their research plans.
The next deadline for letters of intent is June 25.
This flyer provides additional information, but please contact Andy Barton at abarton1@tulane.edu or 504-988-9038 with any questions or to set up a brief call to discuss how your research might fit this request for applications.
| |
NIAID Notice of Special Interest: Inborn Errors of Immunity / Primary Immunodeficiencies (R03, R21, R01 mechanisms)
NOT-AI-24-024
This notice applies to due dates on or after June 5, 2024, and subsequent receipt dates through March 16, 2027.
The purpose of this Notice of Special Interest (NOSI) is to support research on the discovery and characterization of Inborn Errors of Immunity (IEIs), also referred to as Primary Immunodeficiencies, to understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.
More Information
| |
NIH: New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
PAR-24-160
STANDARD DUE DATES: 6/5, 10/5, 2/5
Funds Available and Anticipated Number of Awards: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
The brain is a highly dynamic and consequential organ that undergoes dramatic shifts in cellular composition, connectivity, and activity patterns across the lifespan. A key factor limiting our understanding of these changes, particularly over longer time periods, is the paucity of methods to study longer-term trajectories. Better approaches are needed to link nervous system structure and function, as well as genetic and environmental influences, across time periods and levels of temporal and spatial resolution. This notice of funding opportunity encourages multidisciplinary collaborations to develop novel approaches or improve existing ones for longitudinal or cross-sectional brain measures across the lifespan. The ultimate goal of this funding opportunity is to improve our understanding of how each stage in brain development, starting from prenatal origins, leads to the next one, and how the parameters that are set at each stage predict later brain health or disease.
More Information
| |
REMINDER - Annual Meeting Abstract Deadlines
| |
|
American Society of Hematology (ASH)
Annual Meeting
December 7 - 10, 2024 -
San Diego, CA
ABSTRACT SUBMISSION PERIOD: MAY 30 - AUGUST 1
For more information and key dates for ASH 2024, click HERE.
| |  |
|
American Society for Radiation Oncology (ASTRO) Annual Meeting
Sept 29 - Oct 2, 2024
Washington, DC
CALL FOR LATE-BREAKING ABSTRACTS - JUNE 26 - JULY 12
For more information on late-breaking abstract submissions for ASTRO, click HERE.
| | |
|
Congratulations to
Tulane Cancer Center Member
Doug Chrisey, PhD
Jung Chair of Materials Engineering
Department of Physics and Engineering Physics
School of Science and Engineering
who received a Provost's Proof of Concept (PPOC) Award for his project entitled Single Defects in SiC for Qubits at the recent Tulane Research, Innovation and Creativity Summit.
PPOC funds early-stage research and technology development that presents a viable market application that potentially has a feasible business model. The awarded grants can cover various tasks, including studies, consulting, customer discovery efforts, detailed IP analysis, and prototype development.
"The PPOC funding will allow me to prove a new approach to the large-scale fabrication of Qubits, the most important component necessary for quantum computers." — Doug Chrisey
| |
Tulane Gynecologic Oncologist Jessica Shank, MD, was interviewed by Times-Picayune medical reporter Emily Woodruff for an article on Louisiana's high cervical cancer death rate and reluctance regarding the HPV vaccine. To read the article, click here.
| |
Recent Member Publications | |
|
Bile Spillage as a Prognostic Factor for Gall Bladder Cancer: A Systematic Review and Meta-analysis. Sugumar K, De Mond J, Vijay A, Paramesh AS, Jeon H, Pointer DT, Corsetti RL. J Surg Res. 2024 May 7;299:94-102. doi: 10.1016/j.jss.2024.04.004. Online ahead of print. PMID: 38718689 Review.
Structured illumination microscopy for cancer identification in diagnostic breast biopsies. Behr M, Alizadeh L, Buckner-Baiamonte L, Roberts B, Sholl AB, Brown JQ. PLoS One. 2024 May 9;19(5):e0302600. doi: 10.1371/journal.pone.0302600. eCollection 2024. PMID: 38722960
Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge. Liao H, Lyon CJ, Ying B, Hu T.
Emerg Microbes Infect. 2024 May 20:2356143. doi: 10.1080/22221751.2024.2356143. Online ahead of print.
PMID: 38767202 Review.
Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1). Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S. J Hepatocell Carcinoma. 2024 May 9;11:839-855. doi: 10.2147/JHC.S452152. eCollection 2024. PMID: 38741679
Identification of new microtubule small-molecule inhibitors and microtubule-associated genes against triple negative breast cancer.
Chen J, Lin Z, Fan J, Monzavi-Karbassi B, Kelly T, Post SR, Dai L, Qin Z.
Am J Cancer Res. 2024 Apr 15;14(4):1545-1560. doi: 10.62347/LYDF1241. eCollection 2024. PMID: 38726264
The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression. Murray-Nerger LA, Lozano C, Burton EM, Liao Y, Ungerleider NA, Guo R, Gewurz BE. Nat Commun. 2024 May 16;15(1):4156. doi: 10.1038/s41467-024-48333-x. PMID: 38755141
| |
|
The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.
More Information
| |
Cell Analysis Core
The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.
More Information
| |
Tulane Cancer Center Membership
Please click here for Tulane Cancer Center's membership guidelines and our online application form.
| |
Subscribe to Nexus
If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.
| |
Send Us Your News / Share Your Feedback | |
Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.
| | | | |
